Literature DB >> 1961616

Cyanoacrylate temporary tarsorrhaphy in the management of corneal epithelial defects.

E D Donnenfeld1, H D Perry, D B Nelson.   

Abstract

Cyanoacrylate tarsorrhaphy is an easily administered, painless technique for the temporary management of corneal epithelial defects. We have used the technique in 17 patients to treat persistent epithelial defects and exposure keratitis, as well as following epikeratophakia, allowing the tarsorrhaphy to remain in place for 1 to 15 days (mean, 5.7 days). Eleven of the 17 patients required only one application of cyanoacrylate; five had additional cyanoacrylate applied at the time of the original tarsorrhaphy to produce more extensive lid closure; and one required additional cyanoacrylate on day 3 to produce more extensive lid apposition.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1961616

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  5 in total

1.  Eyelid anaesthesia using tetracaine gel in the treatment of paediatric superglue tarsorrhaphy.

Authors:  A Wong; N Ali
Journal:  Eye (Lond)       Date:  2011-11-11       Impact factor: 3.775

2.  Sutureless amniotic membrane transplantation with cyanoacrylate glue for acute Stevens-Johnson syndrome/toxic epidermal necrolysis.

Authors:  Swapna S Shanbhag; James Chodosh; Hajirah N Saeed
Journal:  Ocul Surf       Date:  2019-03-11       Impact factor: 5.033

3.  Facial nerve palsy: providing eye comfort and cosmesis.

Authors:  Adel H Alsuhaibani
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

Review 4.  Facial Palsy, a Disorder Belonging to Influential Neurological Dynasty: Review of Literature.

Authors:  Ujwala R Newadkar; Lalit Chaudhari; Yogita K Khalekar
Journal:  N Am J Med Sci       Date:  2016-07

5.  Commentary: Tarsorrhaphy: A stitch in time.

Authors:  Manisha Acharya; Abha Gour; Abhishek Dave
Journal:  Indian J Ophthalmol       Date:  2020-01       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.